Fritz biochem gmbh moneyhouse6/2/2023 Here, our diverse team of highly skilled chemists, biologists and physicists with an extensive experience in molecular diagnostics development is dedicated to constantly provide and further develop our latest technologies. CYCLE® Dx provides the complete diagnostic workflow in a miniaturised environment and transfers Point-of-Care testing to the next level: Gather all information needed in a miniaturised, lab-free environment at highly cost-effective set up.We are based in Neuried, with over 350 qm2 state-of-the-art R&D facilities as well as a sophisticated in-house pilot production-site. In addition, all COVID-19 direct RT-PCR kits employ a user-friendly one-step protocol from sample to result, significantly reducing handling effort and time.Furthermore, our CYCLE® Dx platform technology provides for multi-parametric, rapid, sensitive and fully automated molecular testing truly at the Point-of-Care. FRIZ Biochem offers novel, highly innovative and broadly applicable molecular diagnostics solutions (instruments, analytical techniques, chemistries, sample preparation etc.) with special emphasis on Point-of-Care applications.įRIZ Biochem addresses the challenge of providing a combination of simplification and improved information in a time-frame where the result affects medical intervention.Our vision is to make fastest quality diagnostics accessible to anyone, to allow for right treatment at the right time and to provide near patient diagnostics that can be used with as little laboratory equipment and training as possible.With CYCLE® Dx and Lab-direct we have developed two unique patented technology platforms, both enabling for SAFE-molecular diagnostics:Secure = receive reliable results from our certified systemsAdvanced = get multiple parameters for pathogen testing while using one-step protocolsFast = <30min from sample to resultEasy = usable by everyone with no or only little laboratory equipment Thus, our COVID-19 direct RT-PCR kits from the Lab direct series are designed to detect SARS-CoV-2 RNA and COVID-19 mutation(s) in parallel directly from the unprocessed patient sample without any previous additional sample preparation steps, such as RNA extraction. The company initially focused on the development of advanced electronic biochips and gradually integrated the complete workflow of molecular diagnostics into its development efforts. 2004, is a privately-held biotech company located in Neuried near Munich. Our vision is to make fastest quality diagnostics accessible to anyone, to allow for right treatment at the right time and to provide near patient diagnostics that can be used with as little laboratory equipment and training as possible. 20224 Jahre 7 Monate Interfaculty Institute for. Taking Point-of-Care testing to the next level. 2022Heute2 Monate Neuried, Bavaria, Germany University of Tbingen 6 Jahre Doctoral Researcher Okt. When expanded it provides a list of search options that will switch the search inputs to. FRIZ Biochem GmbH 107 (na) tagasubaybay sa LinkedIn. Contact Who is Biochem Headquarters 16 Küstermeyerstrasse, Lohne, Lower Saxony, 49393, Germany Phone Number +49 444292890 Website Revenue 64. Biochemistry / history Germany Glycolysis History, 20th Century United States. Our innovative DNA-detection method allows for advanced (panel-) analysis. The CYCLE® Dx platform is comprised of a compact processing unit and two sophisticated disposable components. Otto Fritz Meyerhof and the elucidation of the glycolytic pathway J Biol Chem. Our unique diagnostic solution provides for multi-parametric, rapid, sensitive and fully automated molecular testing truly at the P oint-of-Care. This button displays the currently selected search type. Otto Fritz Meyerhof and the elucidation of the glycolytic pathway. A primary amine is therefore added to the oligo during synthesis to permit reaction with the desired NHS Ester.Ĭatalog prices for modifications and prices for standard synthesis are found.įRIZ Biochem GmbH, founded in Oct. FRIZ Biochem GmbH in Boydton, VA Expand search. NHS Esters react with free primary amines and result in stable, covalent attachment. When possible, this is done using a modified solid support (CPG) for 3′-modifications or a specialised phosphoramidite reagent for internal and 5′-modifications.Ĭertain modifications are not available as a modified-CPG or phosphoramidite and must be attached to the oligo after synthesis using NHS Ester chemistry. Research & development experience in the synthesis of multiple modified probes enables FRIZ Biochem to offer customers superior reliable technologies & services to optimise their scientific endeavours.Ī wide variety of modifications can be incorporated into an oligonucleotide at the time of synthesis. Highest quality multiple modified oligonucleotides are used for FRIZ Biochem’s DNA -microarrays. International biotechnology industry analysis, data and networking focused on translation, research, development, regulation, commercialization, partnering and funding. 03.06 Genetic testing, molecular diagnostics
0 Comments
Leave a Reply. |